Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial (Q29619886)
Jump to navigation
Jump to search
scientific article (publication date: 8 October 2005)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial |
scientific article (publication date: 8 October 2005) |
Statements
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial (English)
Laakso M
Heine RJ
Taton J
Dormandy JA
Charbonnel B
Eckland DJ
Erdmann E
Massi-Benedetti M
Moules IK
Skene AM
Tan MH
Lefèbvre PJ
Murray GD
Standl E
Wilcox RG
Wilhelmsen L
Betteridge J
Birkeland K
Golay A
Korányi L
Mokán M
Norkus A
Pirags V
Podar T
Scheen A
Scherbaum W
Schernthaner G
Schmitz O
Skrha J
Smith U
8 October 2005
366
1279-89
9493